The Cure Starts Now has funded basic, translational and clinical trials that further efforts in a homerun cure strategy for all cancers, starting with pediatric brain cancer. Our core initiatives focus on diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma (DMG) and Medulloblastoma – though we have a history of funding other pediatric brain tumor research that contributes to our mission. Our research is international and impactful, covering 129 institutions in 29 countries worldwide. While the majority of our research focuses on $100,000 USD and $200,000 USD initiatives, we have funded projects as large as under $5 million USD (with special approval). We have also funded projects both with institutions and industry, provided that they meet grant requirements.
In an effort to balance innovation with transparency, we utilize the SnapGrant research application platform. SnapGrant currently offers free unlimited postings for The Cure Starts Now Foundation's affiliated grant applications. These applications will be proprietary to The Cure Starts Now affiliated funders. If The Cure Starts Now Foundation declines funding your affiliated grant, it will be automatically released to public (non-affiliated) users of SnapGrant in a limited-view format with permission-based access that you approve on a case-by-case basis for potential funding (unless you elect to opt out during the application process).